PPT-Treatment of HCV Coinfection

Author : test | Published Date : 2018-09-16

Navigating the Interactions Jennifer J Kiser PharmD Assistant Professor Department of Pharmaceutical Sciences University of Colorado School of Pharmacy From JJ

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Treatment of HCV Coinfection" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Treatment of HCV Coinfection: Transcript

Navigating the Interactions Jennifer J Kiser PharmD Assistant Professor Department of Pharmaceutical Sciences University of Colorado School of Pharmacy From JJ Kiser MD at Chicago IL May 20 2013 IASUSA . JAMA 20153131232 9 HIV Coinfection brPage 2br Source Osinusi A et al JAMA 20153131232 9 Ledipasvir Sofosbuvir in GT1 with HIV Coinfection NIAID ERADICATE Trial Features NIAID ERADICATE Trial Design Open label phase 2 using fixed dose combination o ION-4. Phase . 3. Treatment. Naïve and Treatment . Experienced. Naggie. S, . et al. . N . Engl. J Med 2015;378:705-13.. HIV Coinfection. Source: . Naggie. S, et al. N . Engl. J Med 2015;378:705-13.. . + Dasabuvir) + RBV in GT1 . TURQUOISE-I. Phase . 2 . Treatment. Naïve and Treatment . Experienced. Wyles. D, et al. 65. th. AASLD. 2014: Abstract . 1939. . . HIV Coinfection. Source: . Wyles. D, et al. 65. HCV Genotype 3 and HIV/HCV Coinfection . What's So "Special" About HCV-GT3 Infection?. Why Talk About HIV/HCV Coinfection?. ALLY-3 Study. ALLY-3 (cont). Daclatasvir Sofosbuvir for 12 Weeks. ALLY-3 Study. Presented by: . Fabian Cretu, Beverly-Ann Oliver, Kristina Miclat, Maeryl Sumagang. PHM142. September 25, 2018. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV. . Case. 47-Year-Old . Man With Asymptomatic HIV Infection. Case (cont). Initial Clinical Presentation. Laboratory Results. HepaScore. ®. A Composite Biomarker Panel for Liver Fibrosis. Hepatic Steatosis in Patients With HIV/HCV Coinfection. Amber Wheeler, MD. WIHS Scientific Meeting. June 30, 2014. Objectives. To discuss:. Background . Aims. Preliminary “rough” data. Future Directions. HIV-infected . persons have increased. odds of . Regional Tuberculosis Consultant. Pennsylvania Department of Health. Senior Vice President for Medical Affairs. Indiana Regional Medical Center. Disclosures. I do not have any financial arrangements or affiliations with a commercial entity.. Antiretroviral. Agents . in Adults and Adolescents . January 2016. AETC . NCRC . Slide Set. About This Presentation. 2. July 2016. www.aidsetc.org. These slides were developed using the April 2015 guidelines, and updated in . Go to: pollev.com/CCO2. or scan the QR code below. *All responses are anonymous and cannot be linked to individual participants.. Contemporary Management of HIV: Managing HIV in Viral Hepatitis Coinfection. University of Chicago. Chicago, Illinois. Challenges in the Management and Treatment of HIV/Hepatitis C Virus Coinfection. FORMATTED: 05/02/2016. Chicago, Illinois: May 9, 2016. From . AI . Aronsohn. Mark Sulkowski, . MD. Professor of Medicine. Medical Director, Viral Hepatitis Center . Johns Hopkins University. Baltimore Maryland USA. Liver disease is the second leading specific causes of death amongst HIV-positive individuals in the D:A:D study. Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV/HBV Coinfection . Study 1249: . Design. Source: Gallant J, et al. . J. . Acquir. Immune . Defic. . Syndr. . 2016;73:294-8.. Baseline ART. (n = 72). GT-1. C212 Trial. Phase . 3. Treatment. Naïve and Treatment . Experienced. Dieterich. . D. , et al. . Clin. Infect Dis. 2014;59:1579-87.. HIV Coinfection. Source: . Dieterich. D. , et al. . Clin.

Download Document

Here is the link to download the presentation.
"Treatment of HCV Coinfection"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.